| abstract |
The present invention provides, inter alia, compounds capable of inhibiting NF-KB. Pharmaceutical compositions containing and methods of using the compounds are also provided herein. Also provided are compositions, methods and kits for treating autoimmune diseases, including but not limited to rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, all comprising and/or utilizing the NF-KB inhibitors described herein. |